E-LIB Suche - Ergebnisse für: Cohen, Aileen

1

Cardiovascular events reported in patients with B-cell mali..:

Moslehi, Javid J. ; Furman, Richard R. ; Tam, Constantine S....
Blood Advances. 8 (2024) 10 - p. 2478-2490 , 2024

Link: https://doi.org/10.1182/..

2

Plain language summary of zanubrutinib or ibrutinib in chro..:

Brown, Jennifer R ; Eichhorst, Barbara ; Hillmen, Peter...
Future Oncology. 20 (2024) 12 - p. 717-726 , 2024

Link: https://doi.org/10.2217/..

3

Genomic landscape of patients in a phase II study of zanubr..:

Xu, Linlin ; Shadman, Mazyar ; Flinn, Ian W....
Haematologica. , 2024

Link: https://doi.org/10.3324/..

4

Similar efficacy of ibrutinib arms across ALPINE and ELEVAT..:

Shadman, Mazyar ; Tedeschi, Alessandra ; Mohseninejad, Leyla...
Blood Cancer Journal. 14 (2024) 1 - p. , 2024

Link: https://doi.org/10.1038/..

5

Characterization of zanubrutinib safety and tolerability pr..:

Brown, Jennifer R. ; Ghia, Paolo ; Jurczak, Wojciech...
Haematologica. , 2024

Link: https://doi.org/10.3324/..

6

Zanubrutinib, Alone and in Combination With Tislelizumab, f..:

Tam, Constantine ; Munoz, Javier ; Cull, Gavin...
HemaSphere. 7 (2023) 4 - p. e870 , 2023

Link: https://doi.org/10.1097/..

7

A Phase 1, Open‐Label, Fixed‐Sequence, Drug–Drug Interactio..:

Tariq, Bilal ; Conto, Stephanie ; Cohen, Aileen..
Clinical Pharmacology in Drug Development. 12 (2023) 8 - p. 832-838 , 2023

Link: https://doi.org/10.1002/..

8

P633: UPDATED SAFETY AND EFFICACY RESULTS OF ZANUBRUTINIB I..:

Shadman, Mazyar ; Y. Levy, Moshe ; Porter, Ryan...
HemaSphere. 7 (2023) S3 - p. e70152b3 , 2023

Link: https://doi.org/10.1097/..

9

PB1926: EFFICACY AND SAFETY OF ONCE DAILY (QD) VS TWICE DAI..:

Tam, Constantine ; Shadman, Mazyar ; Sharman, Jeff...
HemaSphere. 7 (2023) S3 - p. e70124b5 , 2023

Link: https://doi.org/10.1097/..

10

P1679: HEALTH-RELATED QUALITY OF LIFE IN PATIENTS (PTS) WIT..:

Tedeschi, Alessandra ; Tam, Constantine ; Owen, Roger...
HemaSphere. 7 (2023) S3 - p. e27391ea , 2023

Link: https://doi.org/10.1097/..

11

P1136: FIRST INTERIM ANALYSIS OF A PHASE 1 STUDY OF ZANUBRU..:

Zhang, Huilai ; Cheng, Ying ; Yang, Hai-Yan...
HemaSphere. 7 (2023) S3 - p. e1828304 , 2023

Link: https://doi.org/10.1097/..

12

Intrinsically disordered regions of the Msn2 transcription ..:

Mindel, Vladimir ; Brodsky, Sagie ; Cohen, Aileen...
Nucleic Acids Research. 52 (2023) 5 - p. 2260-2272 , 2023

Link: https://doi.org/10.1093/..

13

Zanubrutinib in patients with treatment‐naïve or relapsed/r..:

Castillo, Jorge J ; Kingsley, Edwin C ; Narang, Mohit...
eJHaem. 4 (2023) 1 - p. 301-304 , 2023

Link: https://doi.org/10.1002/..

14

P631: CHARACTERIZATION OF ZANUBRUTINIB SAFETY/TOLERABILITY ..:

Brown, Jennifer R. ; Eichhorst, Barbara ; Ghia, Paolo...
HemaSphere. 7 (2023) S3 - p. e356884b , 2023

Link: https://doi.org/10.1097/..

15

IBCL-117 ASPEN: Long-Term Follow-Up Results of a Phase 3 Ra..:

Castillo, Jorge J. ; Tam, Constantine S. ; Garcia-Sanz, Ramon...
Clinical Lymphoma Myeloma and Leukemia. 22 (2022) - p. S385 , 2022

Link: https://doi.org/10.1016/..